secwatch / observer
8-K filed March 6, 2026, 6:59 PM ET ticker ALB CIK 0000915913
M&A confidence high sentiment positive materiality 0.75

Albemarle completes sale of controlling Ketjen stake for ~$547M; launches $500M debt tender, redeems $650M notes

ALBEMARLE CORP

Machine-readable event card

schema_version
secwatch.filing_event.v1
accession
0000915913-26-000032
form_type
8-K
ticker
ALB
cik
0000915913
company_name
ALBEMARLE CORP
filed_at
2026-03-06T23:59:59+00:00
discovered_at
2026-05-14T18:02:38.024493+00:00
generated_at
2026-05-15T19:14:02.756509+00:00
sec_items
["2.01", "7.01", "8.01", "9.01"]
event_type
m_and_a
sentiment
positive
materiality_score
0.75
calibrated_materiality_score
0.75
confidence
high
secwatch_canonical_url
https://secwatch.observer/filing/0000915913-26-000032
json_url
https://secwatch.observer/filing/0000915913-26-000032.json
markdown_url
https://secwatch.observer/filing/0000915913-26-000032.md
text_url
https://secwatch.observer/filing/0000915913-26-000032.txt
edgar_index_url
https://www.sec.gov/Archives/edgar/data/915913/000091591326000032/0000915913-26-000032-index.htm
edgar_primary_document_url
https://www.sec.gov/Archives/edgar/data/915913/000091591326000032/alb-20260302.htm
generated_by_model
deepseek-v4-flash:cloud@v2
review_status
machine_generated
human_reviewed
false
corrected
false
correction_note
null
correction_timestamp
null
superseded_by
null

Source-grounded claims

baba5a73f9f8be40234ec9ddf4178b5e5c19a9c4

ALBEMARLE CORP completed a disposition involving ChemCat AcquisitionCo, LLC for approximately $547 million in cash (closed 2026-03-02).

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

SEC 8-K Item 2.01/5.01 confidence 0.9 SEC evidence

Comparable filings

BHR

Braemar completes sale of Park Hyatt Beaver Creek for $176M; repays $86.25M convertible notes

Braemar Hotels & Resorts Inc. June 1, 2026, 4:11 PM ET m_and_a Items 2.01, 7.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 7.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

On May 26, 2026, Ashford BC LP and Ashford TRS BC LLC (together “Seller”), indirect subsidiaries of Braemar Hotels & Resorts Inc. (the “Company”), completed the sale of the Park Hyatt Beaver Creek Resort & Spa located in Avon, Colorado (the “Hotel”) pursuant to an Agreement of Purchase and Sale, dated as of April 27, 2026, by and among Seller and Apres Owner, LLC, as purchaser, for $176 million in cash, subject to customary pro-rations and adjustments.

Filing page SEC filing

VREOF

Vireo closes Eaze acquisition for $47M in stock; CEO awarded performance-based RSUs up to 3.5% diluted

Vireo Growth Inc. April 6, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 3.02, 5.02, 7.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 7.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

adjustment with respect to certain of the estimated items included in the Estimated Closing Merger Consideration. In general, the Estimated Closing Merger Consideration is US$47,040,000 in base consideration (the “Base Consideration”), adjusted for certain items as described in the definition of Estimated Closing Merger Consideration in the Merger Agreement,

Filing page SEC filing

CYH

Community Health Systems closes sale of four Arkansas hospitals for $110M cash to Freeman Health System

COMMUNITY HEALTH SYSTEMS INC June 1, 2026, 4:30 PM ET m_and_a Items 2.01, 9.01, 8.01

same fact type: ma_transaction same SEC item: 2.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

the closing of the Transaction, after giving effect to estimated working capital, the assumption of finance leases by the Purchaser and before certain transaction expenses, was $110 million in cash (subject to a post-closing working capital adjustment). The foregoing summary of the Transaction and the terms and conditions of the Purchase Agreement is subject to, and

Filing page SEC filing

RPAY

REPAY closes $372M acquisition of KUBRA, funded with new $500M term loan

Repay Holdings Corp June 1, 2026, 4:14 PM ET m_and_a Items 1.01, 2.01, 1.02, 9.01, 2.03, 7.01

same fact type: ma_transaction same SEC item: 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

KUBRA became an indirect wholly owned subsidiary of the Company. Pursuant to the Purchase Agreement, the aggregate cash purchase price for the Acquisition was approximately $372 million, subject to customary post-closing adjustments. The closing cash consideration was funded with a combination of cash on hand and borrowings under the Credit Agreement described

Filing page SEC filing

AD

Array closes $1.0B spectrum sale to Verizon; declares $11 special dividend

ARRAY DIGITAL INFRASTRUCTURE, INC. June 1, 2026, 4:09 PM ET m_and_a Items 2.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

The purchase price received by Array at the Closing was $1.0 billio n, paid in cash. --- EX-99.1 (EX-99.1) --- Array completes sale of select spectrum assets to Verizon for $1.0 billion Board declares special dividend of $11.00 per share CHICAGO (June 1, 2026) – Array Digital Infrastructure, Inc. (NYSE: AD) (Array SM ) today announced the successful closing of

Filing page SEC filing

SSM

Sono Group exits solar: sells Sono Motors and €10.5M loan to management for €1 each

Sono Group N.V. May 8, 2026, 7:59 PM ET m_and_a Items 2.05, 1.01, 2.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

true 0001840416 0001840416 2026-05-04 2026-05-04 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 __________________________ FORM 8-K/A (Amendment No. 1) __________________________ CURRENT REPORT PURSUANT TO SECTION 13 OR 15(D) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): May 4, 2026

Filing page SEC filing

EWCZ

European Wax Center completes take-private by General Atlantic at $5.80/share; stock delisted

European Wax Center, Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 1.02, 2.01, 2.03, 3.01, 3.03, 5.02, 5.03, 5.01, 8.01, 9.01

same fact type: ma_transaction same SEC item: 2.01, 8.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

excluded shares pursuant to the terms of the Merger Agreement, was cancelled and extinguished and automatically converted into the right to receive an amount in cash equal to $5.80 per share of Class A Common Stock, without interest thereon (the “ Class A Per Share Price ”), (ii) each share of the Company’s Class B common stock, par value $0.00001 per share

Filing page SEC filing

APAD

Enhanced Group completes de-SPAC merger with Enhanced Ltd; redemptions of $201.7M

Enhanced Group Inc. May 8, 2026, 7:59 PM ET m_and_a Items 1.01, 2.01, 5.06, 3.02, 9.01, 4.01, 3.01, 3.03, 5.01, 5.02, 5.03, 5.05, 7.01

same fact type: ma_transaction same SEC item: 2.01, 7.01, 9.01 same event type: m_and_a similar materiality

This filing

arrangements), and marketing catalysts and related products on a global basis. In connection with the Sale, Albemarle expects to receive an aggregate amount of approximately $547 million in cash, inclusive of $22 million in cash included with Ketjen at the time of the Sale. Together with the sale of its 50% interest in the Eurecat joint venture to Axens SA,

Comparable filing

On May 7, 2026, as contemplated by the Business Combination Agreement and as described in the section titled “ The BCA Proposal ” beginning on pa ge 180 of the Proxy Statement/Prospectus, the Company, Enhanced and Merger Sub consummated the business combination contemplated by the Business Combination Agreement, whereby: • Merger Sub merged with and into Enhanced (the “First Merger”), with Enhanced surviving the merger as a wholly owned subsidiary of the Company;

Filing page SEC filing

Source: SEC EDGAR
accession 0000915913-26-000032

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.